GTO ID | GTD0009 |
Accession | GSE229785 |
Altered gene | miR-28 |
Gene xrefs |
Gene ID:
407020
Gene symbol: MIR28 Ensembl ID: ENSG00000207651 |
Treatment | miR-28 mimics |
Control | GSM7177654;GSM7177655 |
Case | GSM7177644;GSM7177645 |
Disease | Diffuse Large B Cell Lymphoma |
Disease information |
Disease group: Cancer Definition: A B-cell lymphoma that is a cancer of B cells presenting as an aggressive tumour which can arise in virtually any part of the body. Xref: DO:0050745 | EFO:0000403 | EFO:0001642 | EFO:1000157 | EFO:1000490 | ICD10:C83.3 | MONDO:0002571 | MONDO:0018905 | MSH:D016403 | NCI:C8851 | ORDO:544 |
Organism | Homo sapiens |
Tissue/Cell type | Diffuse large B cell lymphoma tumor cell line |
Characteristics | time of ibrutinib treatment: 20h |
Strategy | RNA-seq |
Platform | GPL20301 |
Vector information | |||||||||
|
Gene Name | AveExpr Control | AveExpr Case | Log2FC | P-value | Adjusted P-value | Regulation | Boxplot |
---|
TF | Regulation | Gene Ratio | Bg Ratio | P-value | Adjusted P-value | Enriched Gene | Count |
---|
ID | Terms | Size | ES | NES | P-value | Adjusted P-value | Plot |
---|
Cell Type | Source | Regulation | Gene Ratio | Bg Ratio | Hypergeometric P-value | Adjusted P-value | Marker Gene |
---|